We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Charles River (CRAI) Announces bioStrategies Acquisition
Read MoreHide Full Article
Charles River Associates (CRAI - Free Report) have had an impressive run in the past month. The stock gained 20.5%, significantly outperforming the 5.7% rise of the industry it belongs to and the 5.4% rally of the Zacks S&P 500 composite.
The company yesterday announced that it has acquired Chicago-based consulting firm, bioStrategies Group, which specializes in developing commercial strategies for new and existing healthcare products and technologies, and is now a part of Charles River’s Life Sciences Practice.
The transaction was completed on Nov 29, with Charles River buying all of the assets of bioStrategies and adding 17 employees including Chris Schneider and Mike Kaestle. Both are now vice presidents at CRAI’s Life Sciences Practice.
Charles River’s Benefits
The acquisition expands Charles River’s geographic presence and adds to its already strong team of highly qualified senior officials who are focused on generating balanced and profitable growth across the organization through optimum organic and inorganic means, strengthening client relationships and simplifying internal processes.
"I look forward to working with Mike and Chris, both of whom have the kind of institutional knowledge and subject matter expertise that our clients rely on to help them anticipate trends and break through strategic barriers," said CRA’s Life Sciences Practice Leader and Vice President, Gregory K. Bell. "Furthermore, they are bringing a strong team of experienced consultants and we look forward to collaborating with them in addressing our clients’ most critical needs," he added.
Some better-ranked stocks in the broader Zacks Business Services sector are Booz Allen Hamilton Holding Corporation (BAH - Free Report) and Cross Country Healthcare, Inc. (CCRN - Free Report) .
Booz Allencarries a Zacks Rank #2 (Buy) at present. BAH has a long-term earnings growth expectation of 8.9%.
Booz Allen delivered a trailing four-quarter earnings surprise of 8.8% on average.
Cross Country Healthcare is currently a Zacks #2 Ranked stock. CCRN has a long-term earnings growth expectation of 6%.
CCRN delivered a trailing four-quarter earnings surprise of 10.1% on average.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Charles River (CRAI) Announces bioStrategies Acquisition
Charles River Associates (CRAI - Free Report) have had an impressive run in the past month. The stock gained 20.5%, significantly outperforming the 5.7% rise of the industry it belongs to and the 5.4% rally of the Zacks S&P 500 composite.
Charles River Associates Price
Charles River Associates price | Charles River Associates Quote
The company yesterday announced that it has acquired Chicago-based consulting firm, bioStrategies Group, which specializes in developing commercial strategies for new and existing healthcare products and technologies, and is now a part of Charles River’s Life Sciences Practice.
The transaction was completed on Nov 29, with Charles River buying all of the assets of bioStrategies and adding 17 employees including Chris Schneider and Mike Kaestle. Both are now vice presidents at CRAI’s Life Sciences Practice.
Charles River’s Benefits
The acquisition expands Charles River’s geographic presence and adds to its already strong team of highly qualified senior officials who are focused on generating balanced and profitable growth across the organization through optimum organic and inorganic means, strengthening client relationships and simplifying internal processes.
"I look forward to working with Mike and Chris, both of whom have the kind of institutional knowledge and subject matter expertise that our clients rely on to help them anticipate trends and break through strategic barriers," said CRA’s Life Sciences Practice Leader and Vice President, Gregory K. Bell. "Furthermore, they are bringing a strong team of experienced consultants and we look forward to collaborating with them in addressing our clients’ most critical needs," he added.
Zacks Rank and Stocks to Consider
Charles River currently carries a Zacks Rank #3 (Hold). You can seethe complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the broader Zacks Business Services sector are Booz Allen Hamilton Holding Corporation (BAH - Free Report) and Cross Country Healthcare, Inc. (CCRN - Free Report) .
Booz Allencarries a Zacks Rank #2 (Buy) at present. BAH has a long-term earnings growth expectation of 8.9%.
Booz Allen delivered a trailing four-quarter earnings surprise of 8.8% on average.
Cross Country Healthcare is currently a Zacks #2 Ranked stock. CCRN has a long-term earnings growth expectation of 6%.
CCRN delivered a trailing four-quarter earnings surprise of 10.1% on average.